Atovaquone-resistant Plasmodium falciparum in Central Africa
Phase 4
- Conditions
- target disease - malaria
- Registration Number
- JPRN-UMIN000003813
- Lead Sponsor
- Aix-Marseille Universite
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
signs and symptoms of severe and complicated malaria (as defined by the World Health Organization), mixed infections with other Plasmodium species, persistent vomiting, hematocrit less than 15%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adequate clinical and parasitological response versus treatment failure on day 28, as defined by the World Health Organization
- Secondary Outcome Measures
Name Time Method parasite and fever clearance times